{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-254697","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2025-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.712551+00:00","generated_at":"2026-05-17T01:42:45.213476+00:00","sec_items":["1.01","1.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"confidence":"high","headline":"Imagenebio terminates Miragene transition agreement; extends partial services for 6 months at $200K","bullets":["Elected not to auto-renew transition services agreement with Miragene Inc. dated July 25, 2025.","Extended term six months for subset of services (chemistry, manufacturing, controls, translational sciences).","Total fees for Miragene Extension Services: $200,000.","End of initial term triggers partial extension; full termination after extension period."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-254697","json":"https://secwatch.observer/filing/0001193125-25-254697.json","markdown":"https://secwatch.observer/filing/0001193125-25-254697.md","text":"https://secwatch.observer/filing/0001193125-25-254697.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525254697/0001193125-25-254697-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525254697/d24830d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:42:45.213476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}